Aptamer anchored nano-architectures for treatment of drug resistant cancer

• At: Glasgow (Scotland) (2018)
• Type: Poster
• Poster code: POS-FDP-010
• By: KESHARWANI, Prashant (Central Drug Research Institute, Lucknow, Pharmaceutics and Pharmacokinetics)
• Co-author(s): Prashant Kesharwani
  
• Abstract:

  Background

   
  Despite numerous advances in surgical treatment, chemotherapy and molecular 
  targeted agents for NSCLC, metastasis and multidrug resistance are still major causes for 
  failures in treating lung cancer patients
  [3]
  . Thus, it is highly desirable to develop new therapeutic 
  approaches beyond conventional treatment for NSCLC

  Despite

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login